Zander Therapeutics, Inc
company.status.inactiveCIK 1718644fmd_1DMWD72Q0CCN8Z8SNQVHMR4XGRManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2016 to Sep 30, 2019, 10 periods
| Line item | FY2017 | FY2018 | FY2019 |
|---|---|---|---|
| Realized investment gains (losses) | – | – | 2 |
| Research and development | – | 2 | 1 |
| Selling, general and administrative | – | 0 | 1 |
| Operating income | – | (2) | (2) |
| Interest expense | – | – | 0 |
| Other non-operating income (expense) | – | (0) | 2 |
| Net income | (0) | (2) | 0 |
| Net income to common shareholders | – | (2) | 0 |